节点文献

APP/PS1转基因鼠脑内小泛素化修饰物-1上调可能参与阿尔茨海默病老年斑形成和神经突起变性的调节

Potential involvement of abnormal increased SUMO-1 in modulation of the formation of Alzheimer’s disease senile plaques and neuritic dystrophy in APP/ PS1 transgenic mice

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 赵晓燕王丹丹单烨朱粹青

【Author】 ZHAO Xiao-Yan, WANG Dan-Dan, SHAN Ye, ZHU Cui-Qing State Key Laboratory of Medical Neurobiology and Institutes of Brain Science, Fudan University, Shanghai 200032, China

【机构】 复旦大学上海医学院神经生物学国家重点实验室

【摘要】 小泛素化修饰物(small ubiquitin-related modifier,SUMO)是一类重要的类泛素蛋白,研究显示一些神经退行性疾病相关蛋白可以被SUMO化修饰。本文旨在观察APP/PS1转基因阿尔茨海默病(Alzheimer’s disease,AD)鼠中SUMO-1表达及修饰的变化,并探讨SUMO-1与AD病理的关系。采用免疫印迹的方法检测12月龄的APP/PS1转基因AD鼠脑内SUMO-1表达及修饰的变化,同时用免疫共沉淀及免疫荧光的方法研究AD鼠脑内SUMO-1与tau、APP和Aβ的关系。结果显示:(1)与正常野生型小鼠相比,AD鼠脑内SUMO-1表达及其修饰的蛋白增加,同时伴有泛素化蛋白的增加;(2)AD鼠大脑皮层的RIPA可溶蛋白组份中,SUMO-1修饰的tau增加,而AT8抗体识别的磷酸化tau的SUMO-1修饰减少,但422位点磷酸化tau的SUMO-1修饰没有明显改变;(3)SUMO-1与磷酸化tau、APP及Aβ免疫荧光双标显示,在AD鼠脑内SUMO-1可在老年斑的中部和周围分布,并且SUMO-1与AT8识别的磷酸化tau在老年斑周围的变性神经突起中有相对较多的共存,但与APP、PS422识别的磷酸化tau和Aβ的共定位很少。以上结果提示,SUMO-1在APP/PS1转基因AD小鼠脑内表达增加,并可能参与变性神经突起及老年斑形成的调节。

【Abstract】 Small ubiquitin-related modifiers (SUMOs) belong to an important class of ubiquitin like proteins. SUMOylation is a posttranslational modification process that regulates the functional properties of many proteins, among which are several proteins implicated in neurodegenerative diseases. This study was aimed to investigate the changes of SUMO-1 expression and modification, and the relationship between SUMO-1 and Alzheimer’s disease (AD) pathology in APP/PS1 transgenic AD mice. Using Western blot, co-immunoprecipitation and immunofluorescent staining methods, the SUMO-1 expression and modification and its relation to tau, amyloid precursor protein (APP) and β-amyloid protein (Aβ) in the 12-month-old APP/PS1 transgenic AD mice were analyzed. The results showed that: (1) Compared with the normal wild-type mice, the expression and modification of SUMO-1 increased in brain of AD mice, which was accompanied by an increase of ubiquitination; (2) In RIPA soluble protein fraction of cerebral cortex, co-immunoprecipitation analysis showed tau SUMOylated by SUMO-1 increased in AD mice, however, AT8 antibody labeled phosphorylated tau was less SUMOylated whereas PS422 antibody labeled phosphorylated tau was similar to control mice; (3) Double immunofluorescent staining showed that SUMO-1 could distributed in amyloid plaques, appearing that some of SUMO-1 diffused in centre of some plaques and some of SUMO-1 co-localized with AT8 labeled phosphorylated tau forming punctate aggregates around amyloid plaques which was concerned as dystrophic neurites, however, less Aβ, APP and PS422 labeled phosphorylated tau were found colocalized with SUMO-1. These results suggest that SUMO-1 expression and modification increase abnormally in transgenic AD mice, which may participate in modulation of the formation of senile plaques and dystrophic neurites.

【基金】 supported by the National Natural Science Foundation of China(No.81071017);Shanghai Science and Tech-nology Development Foundation,China(No.10DZ1976000)
  • 【文献出处】 生理学报 ,Acta Physiologica Sinica , 编辑部邮箱 ,2013年03期
  • 【分类号】R749.16
  • 【被引频次】19
  • 【下载频次】426
节点文献中: 

本文链接的文献网络图示:

本文的引文网络